Biomarkers for Alzheimer’s Disease: A Comprehensive Overview

Q: Q. How do biomarkers aid in early diagnosis?

A. Biomarkers can identify brain changes years before symptoms appear, allowing for earlier interventions and potential slowing of disease progression.

Q: Q. Can a blood test detect Alzheimer’s?

A. Emerging blood tests measuring amyloid and tau levels show promise, but they are still being refined for widespread clinical use.

Q: Q. What imaging techniques are used as biomarkers?

A. PET scans detect amyloid plaques, while MRI scans assess brain shrinkage linked to Alzheimer’s progression.

Q: Q. Are Alzheimer’s biomarkers useful for tracking disease progression?

A. Yes, biomarkers help monitor brain changes over time, assisting doctors in adjusting treatment plans and evaluating new therapies.

Blog
Biomarkers for Alzheimer’s Disease: A Comprehensive Overview

Frequently Asked Questions

Q. What are the biomarkers for Alzheimer’s disease?

A. They are biological indicators, such as amyloid-beta and tau proteins, found in cerebrospinal fluid, blood, or brain imaging, that help detect the disease.